Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum

American Journal of Physiology - Endocrinology and Metabolism

Volumn 278, Issue 6 41-6, 2000, Pages

  Hansen, Lene ^a   Hartmann, Bolette ^a   Bisgaard, Thue ^a   Mineo, Hitoshi ^a   Jørgensen, Peer N ^b   Holst, Jens J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Bombesin; Enteric nervous system; Gastrointestinal hormones; Immunoneutralization; L cells; Paracrine activity

Indexed keywords

ACETYLCHOLINE; BOMBESIN; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1; MONOCLONAL ANTIBODY; PHENTOLAMINE; SOMATOSTATIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; ENDOCRINE CELL; GEL FILTRATION; HORMONAL REGULATION; INTESTINE INNERVATION; MOTOR ACTIVITY; NERVE STIMULATION; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN SECRETION; REGULATORY MECHANISM; SWINE;

EID: 0033921741     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.2000.278.6.e1010     Document Type: Article

References (44)

1. Abad ME, Taverne-Thiele JJ, and Rombout JH. Immunocytochemical and ultrastructural characterization of coexistence of pancreatic polypeptide and glucagon-like immunoreactivity in the pancreatic endocrine cells of Sparus auratus L. (Teleostei). Gen Comp Endocrinol 70: 9-19, 1988.
2. Baldissera FG, Nielsen OV, and Holst JJ. The intestinal mucosa preferentially releases somatostatin-28 in pigs. Regul Pept 11: 251-262, 1985.
3. Brand CL, Rolin B, Jorgensen PN, Svendsen I, Kristensen JS, and Holst JJ. Immunoneutralization of endogenous glucagon with monoclonal glucagon antibody normalizes hyperglycaemia in moderately streptozotocin-diabetic rats. Diabetologia 37: 985-993, 1994.
4. Brubaker PL. Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides. Endocrinology 128: 3175-3182, 1991.
5. Brubaker PL, Efendic S, and Greenberg GR. Truncated and full-length glucagon-like peptide-1 (GLP-1) differentially stimulate intestinal somatostatin release. Endocrine 6: 91-95, 1997.
6. Buchan AM, Barber DL, Gregor M, and Soll AH. Morphologic and physiologic studies of canine ileal enteroglucagon-containing cells in short-term culture. Gastroenterology 93: 791-800, 1987.
7. Damholt AB, Buchan AM, and Kofod H. Glucagon-like-peptide-1 secretion from canine L-cells is increased by glucose-dependent-insulinotropic peptide but unaffected by glucose. Endocrinology 139: 2085-2091, 1998.
8. Deacon CF, Johnsen AH, and Holst JJ. Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 80: 952-957, 1995.
9. Deacon CF, Pridal L, Klarskov L, Olesen M, and Holst JJ. Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig. Am J Physiol Endocrinol Metab 271: E458-E464, 1996.
10. Drucker DJ, Erlich P, Asa SL, and Brubaker PL. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 93: 7911-7916, 1996.
11. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, and Marks V. Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute postprandial and 24-h secretion patterns. J Endocrinol 138: 159-166, 1993.
12. Francis BH, Baskin DG, Saunders DR, and Ensinck JW. Distribution of somatostatin-14 and somatostatin-28 gastrointestinal-pancreatic cells of rats and humans. Gastroenterology 99: 1283-1291, 1990.
13. Hansen L, Mineo H, Bisgaard T, Jorgensen PN, and Holst JJ. Somatostatin is a major, paracrine regulator of glucagon-like peptide-1 (GLP-1) secretion in isolated perfused porcine ileum (Abstract). Regul Pept 64: 61, 1996.
14. Herrmann C, Goke R, Richter G, Fehmann HC, Arnold R, and Goke B. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients. Digestion 56: 117-126, 1995.
15. Herrmann-Rinke C, Horsch D, McGregor GP, and Goke B. Galanin is a potent inhibitor of glucagon-like peptide-1 secretion from rat ileum. Peptides 17: 571-576, 1996.
16. Herrmann-Rinke C, Voge A, Hess M, and Goke B. Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides. J Endocrinol 147: 25-31, 1995.
17. Hilsted L and Holst JJ. On the accuracy of radioimmunological determination of somatostatin in plasma. Regul Pept 4: 13-31, 1982.
18. Holst JJ. Enteroglucagon. Annu Rev Physiol 59: 257-271, 1997.
19. Holst JJ, Jensen SL, Nielsen OV, and Schwartz TW. Oxygen supply, oxygen consumption, and endocrine and exocrine secretions of the isolated, perfused, porcine pancreas. Acta Physiol Scand 109: 7-13, 1980.
20. Holst JJ, Jørgensen PN, Rasmussen TN, and Schmidt P. Somatostatin restraint of gastrin secretion in pigs revealed by monoclonal antibody immunoneutralization. Am J Physiol Gastrointest Liver Physiol 263: G908-G912, 1992.
21. Holst JJ, Kreutzfeldt M, Holm G, Jensen E, Poulsen JS, Sparso B, and Schmidt A. Absence of true pancreatic glucagon but persistence of circulating pancreatic glucagon-like immunoreactivity after pancreatectomy in pigs. Diabete Metab 4: 75-79, 1978.
22. Layer P, Holst JJ, Grandt D, and Goebell H. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. Dig Dis Sci 40: 1074-1082, 1995.
23. Marco J, Hedo JA, and Villaneuva ML. Inhibition of intestinal glucagon-like immunoreactivity (GLI) secretion by somatostatin in man. J Clin Endocrinol Metab 44: 695-698, 1977.
24. Martin PA and Faulkner A. Effects of somatostatin-28 on circulating concentrations of insulin and gut hormones in sheep. J Endocrinol 151: 107-112, 1996.
25. Messell T, Harling H, Poulsen SS, Bersani M, and Holst JJ. Extrinsic control of the release of galanin and VIP from intrinsic nerves of isolated, perfused, porcine ileum. Regul Pept 38: 179-198, 1992.
26. Mojsov S, Weir GC, and Habener JF. Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79: 616-619, 1987.
27. Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, and Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91: 301-307, 1993.
28. Nauck MA, Niedereichholz U, Ettler R, Holst JJ, Orskov C, Ritzel R, and Schmiegel WH. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol Endocrinol Metab 273: E981-E988, 1997.
29. Orskov C, Holst JJ, Knuhtsen S, Baldissera FG, Poulsen SS, and Nielsen OV. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 119: 1467-1475, 1986.
30. Orskov C, Jeppesen J, Madsbad S, and Holst JJ. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J Clin Invest 87: 415-423, 1991.
31. Orskov C, Rabenhoj L, Wettergren A, Kofod H, and Holst JJ. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans. Diabetes 43: 535-539, 1994.
32. Orskov C, Wettergren A, and Holst JJ. Secretion of the incretin hormones glucagon-like peptide-1 and gastric inhibitory polypeptide correlates with insulin secretion in normal man throughout the day. Scand J Gastroenterol 31: 665-670, 1996.
33. Patel YC, Panetta R, Escher E, Greenwood M, and Srikant CB. Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype. J Biol Chem 269: 1506-1509, 1994.
34. Plaisancie P, Bernard C, Chayvialle JA, and Cuber JC. Regulation of glucagon-like peptide-1-(7-36) amide secretion by intestinal neurotransmitters and hormones in the isolated vascularly perfused rat colon. Endocrinology 135: 2398-2403, 1994.
35. Sasaki H, Rubalcava B, Baetens D, Blazquez E, Srikant CB, Orci L, and Unger RH. Identification of glucagon in the gastrointestinal tract. J Clin Invest 56: 135-145, 1975.
36. Schmidt P, Rasmussen TN, and Holst JJ. Nervous control of the release of substance P and neurokinin A from the isolated perfused porcine ileum. J Auton Nerv Syst 38: 85-95, 1992.
37. Schmidt P, Rasmussen TN, and Holst JJ. Release of immunoreactive somatostatin, vasoactive intestinal polypeptide (VIP), and galanin during propulsive complexes in isolated pig ileum. Peptides 14: 215-220, 1993.
38. Schmidt PT and Holst JJ. Use of antagonists to define tachykininergic control of intestinal motility in pigs. Peptides 18: 373-379, 1997.
39. Schusdziarra V, Rouiller D, and Unger RH. Oral administration of somatostatin reduces postprandial plasma triglycerides, gastrin and gut glucagon-like immunoreactivity. Life Sci 24: 1595-1600, 1979.
40. Scrocchi LA, Brown TJ, and Drucker DJ. Leptin sensitivity in nonobese glucagon-like peptide I receptor -/-mice. Diabetes 46: 2029-2034, 1997.
41. Skak-Nielsen T, Holst JJ, Baldissera FG, and Poulsen SS. Localization in the gastrointestinal tract of immunoreactive prosomatostatin. Regul Pept 19: 183-195, 1987.
42. Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, and Holst JJ. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38: 665-673, 1993.
43. Wojdemann M, Wettergren A, Hartmann B, and Holst JJ. Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scand J Gastroenterol 33: 828-832, 1998.
44. Yoshida T and Kondo M. Effect of acetylcholine on the secretion of gut glucagon immunoreactivity and gut glucagon-like immunoreactivity in pancreatectomized dogs. Endocrinol Jpn 27: 33-38, 1980.